This Article Full Text Full Text (PDF) All Versions of this Article: 49/6/1307    most recent HYPERTENSIONAHA.107.087874v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lohmeier, T. E. Articles by Kieval, R. S. Search for Related Content PubMed PubMed Citation Articles by Lohmeier, T. E. Articles by Kieval, R. S. Related Collections Other hypertension

(Hypertension. 2007;49:1307.)
© 2007 American Heart Association, Inc.

Original Articles

Prolonged Activation of the Baroreflex Abolishes Obesity-Induced Hypertension

Thomas E. Lohmeier; Terry M. Dwyer; Eric D. Irwin; Martin A. Rossing; Robert S. Kieval

From the Department of Physiology (T.E.L., T.M.D.), University of Mississippi Medical Center, Jackson; Trauma Services (E.D.I.), North Memorial Medical Center, Robbinsdale, Minn; and CVRx, Inc. (M.A.R., R.S.K.), Maple Grove, Minn.

Correspondence to Thomas E. Lohmeier, Department of Physiology, University of Mississippi Medical Center, 2500 North State St, Jackson, MS 39216-4505. E-mail tlohmeier{at}physiology.umsmed.edu

Prolonged electrical activation of the carotid baroreflex produces sustained reductions in sympathetic activity and arterial pressure in normotensive dogs. The main goal of this study was to assess the influence of prolonged baroreflex activation on arterial pressure and neurohormonal responses in 6 dogs with obesity-induced hypertension. After control measurements, the diet was supplemented with cooked beef fat for 6 weeks, whereas sodium intake was held constant. After 4 weeks of the high-fat diet, there were increments in body weight from 25.8±0.7 to 38.6±1.0 kg, mean arterial pressure from 97±2 to 110±3 mm Hg, heart rate from 67±3 to 91±4 bpm, and plasma norepinephrine concentration from 141±35 to 280±52 pg/mL. Plasma glucose and insulin concentrations were elevated, but increases in plasma renin activity during the initial weeks of the high-fat diet were not sustained. During week 5, baroreflex activation resulted in sustained reductions in mean arterial pressure, heart rate, and plasma norepinephrine concentration; at the end of week 5, these values were 87±2 mm Hg, 77±4 bpm, and 166±45 pg/mL, respectively. These suppressed values returned to week 4 levels during a 7-day recovery period after baroreflex activation. There were no changes in plasma glucose or insulin concentrations, or plasma renin activity during prolonged baroreflex activation. These findings indicate that baroreflex activation can chronically suppress the sympathoexcitation associated with obesity and abolish the attendant hypertension while having no effect on hyperinsulinemia or hyperglycemia.

Key Words: baroreflex • hypertension • heart rate • obesity • sympathetic nervous system • norepinephrine • renin–angiotensin system

This article has been cited by other articles:

				K. Wustmann, J. P. Kucera, I. Scheffers, M. Mohaupt, A. A. Kroon, P. W. de Leeuw, J. Schmidli, Y. Allemann, and E. Delacretaz Effects of Chronic Baroreceptor Stimulation on the Autonomic Cardiovascular Regulation in Patients With Drug-Resistant Arterial Hypertension Hypertension, September 1, 2009; 54(3): 530 - 536. [Abstract] [Full Text] [PDF]

				T. E. Lohmeier, D. A. Hildebrandt, T. M. Dwyer, R. Iliescu, E. D. Irwin, A. W. Cates, and M. A. Rossing Prolonged Activation of the Baroreflex Decreases Arterial Pressure Even During Chronic Adrenergic Blockade Hypertension, May 1, 2009; 53(5): 833 - 838. [Abstract] [Full Text] [PDF]

				M. J. Joyner, N. Charkoudian, and B. G. Wallin A sympathetic view of the sympathetic nervous system and human blood pressure regulation Exp Physiol, June 1, 2008; 93(6): 715 - 724. [Abstract] [Full Text] [PDF]

				I. Biaggioni Should We Target the Sympathetic Nervous System in the Treatment of Obesity-Associated Hypertension? Hypertension, February 1, 2008; 51(2): 168 - 171. [Full Text] [PDF]

				I. H. Zucker, J. F. Hackley, K. G. Cornish, B. A. Hiser, N. R. Anderson, R. Kieval, E. D. Irwin, D. J. Serdar, J. D. Peuler, and M. A. Rossing Chronic Baroreceptor Activation Enhances Survival in Dogs With Pacing-Induced Heart Failure Hypertension, November 1, 2007; 50(5): 904 - 910. [Abstract] [Full Text] [PDF]

				M. G. Mohaupt, J. Schmidli, and F. C. Luft Management of Uncontrollable Hypertension With a Carotid Sinus Stimulation Device Hypertension, November 1, 2007; 50(5): 825 - 828. [Full Text] [PDF]